Reverse Merger Returns Vary Widely: Weighing the Risk
By Trista Morrison
Monday, July 25, 2011
Investors in Novacea Inc. prior to its reverse merger with Transcept Pharmaceuticals Inc. three years ago might be forgiven for saying, "I told you so."
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.